The global Non-alcoholic Steatohepatitis market size was estimated at USD 2532 million in 2024 and is projected to reach USD 13664.37 million by 2032, exhibiting a CAGR of 20.60% during the forecast period.
North America Non-alcoholic Steatohepatitis market size was estimated at USD 913.33 million in 2024, at a CAGR of 17.66% during the forecast period of 2025 through 2032.
Report Overview
Non-alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease (NAFLD). NAFLD is caused by buildup of fat in the liver. When this buildup causes inflammation and damage, it is known as NASH, which can lead to scarring of the liver.
This report provides a deep insight into the global Non-alcoholic Steatohepatitis market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Non-alcoholic Steatohepatitis Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Non-alcoholic Steatohepatitis market in any manner.
Global Non-alcoholic Steatohepatitis Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- AstraZeneca
- Pfizer
- GSK
- Novo Nordisk
- Roche
- AbbVie
- Galectin Therapeutics
- Galmed Pharmaceuticals
- Gilead
- Intercept pharma
- Non-alcoholic Steatohepatitis
- Takeda
Market Segmentation (by Type)
Market Segmentation (by Application)
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Non-alcoholic Steatohepatitis Market
- Overview of the regional outlook of the Non-alcoholic Steatohepatitis Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Non-alcoholic Steatohepatitis
1.2 Key Market Segments
1.2.1 Non-alcoholic Steatohepatitis Segment by Type
1.2.2 Non-alcoholic Steatohepatitis Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Non-alcoholic Steatohepatitis Market Overview
2.1 Global Market Overview
2.1.1 Global Non-alcoholic Steatohepatitis Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Non-alcoholic Steatohepatitis Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Non-alcoholic Steatohepatitis Market Competitive Landscape
3.1 Global Non-alcoholic Steatohepatitis Sales by Manufacturers (2019-2025)
3.2 Global Non-alcoholic Steatohepatitis Revenue Market Share by Manufacturers (2019-2025)
3.3 Non-alcoholic Steatohepatitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Non-alcoholic Steatohepatitis Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Non-alcoholic Steatohepatitis Sales Sites, Area Served, Product Type
3.6 Non-alcoholic Steatohepatitis Market Competitive Situation and Trends
3.6.1 Non-alcoholic Steatohepatitis Market Concentration Rate
3.6.2 Global 5 and 10 Largest Non-alcoholic Steatohepatitis Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Non-alcoholic Steatohepatitis Industry Chain Analysis
4.1 Non-alcoholic Steatohepatitis Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Non-alcoholic Steatohepatitis Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Non-alcoholic Steatohepatitis Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non-alcoholic Steatohepatitis Sales Market Share by Type (2019-2025)
6.3 Global Non-alcoholic Steatohepatitis Market Size Market Share by Type (2019-2025)
6.4 Global Non-alcoholic Steatohepatitis Price by Type (2019-2025)
7 Non-alcoholic Steatohepatitis Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non-alcoholic Steatohepatitis Market Sales by Application (2019-2025)
7.3 Global Non-alcoholic Steatohepatitis Market Size (M USD) by Application (2019-2025)
7.4 Global Non-alcoholic Steatohepatitis Sales Growth Rate by Application (2019-2025)
8 Non-alcoholic Steatohepatitis Market Consumption by Region
8.1 Global Non-alcoholic Steatohepatitis Sales by Region
8.1.1 Global Non-alcoholic Steatohepatitis Sales by Region
8.1.2 Global Non-alcoholic Steatohepatitis Sales Market Share by Region
8.2 North America
8.2.1 North America Non-alcoholic Steatohepatitis Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Non-alcoholic Steatohepatitis Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Non-alcoholic Steatohepatitis Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Non-alcoholic Steatohepatitis Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Non-alcoholic Steatohepatitis Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Non-alcoholic Steatohepatitis Market Production by Region
9.1 Global Production of Non-alcoholic Steatohepatitis by Region (2019-2025)
9.2 Global Non-alcoholic Steatohepatitis Revenue Market Share by Region (2019-2025)
9.3 Global Non-alcoholic Steatohepatitis Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Non-alcoholic Steatohepatitis Production
9.4.1 North America Non-alcoholic Steatohepatitis Production Growth Rate (2019-2025)
9.4.2 North America Non-alcoholic Steatohepatitis Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Non-alcoholic Steatohepatitis Production
9.5.1 Europe Non-alcoholic Steatohepatitis Production Growth Rate (2019-2025)
9.5.2 Europe Non-alcoholic Steatohepatitis Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Non-alcoholic Steatohepatitis Production (2019-2025)
9.6.1 Japan Non-alcoholic Steatohepatitis Production Growth Rate (2019-2025)
9.6.2 Japan Non-alcoholic Steatohepatitis Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Non-alcoholic Steatohepatitis Production (2019-2025)
9.7.1 China Non-alcoholic Steatohepatitis Production Growth Rate (2019-2025)
9.7.2 China Non-alcoholic Steatohepatitis Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 AstraZeneca
10.1.1 AstraZeneca Non-alcoholic Steatohepatitis Basic Information
10.1.2 AstraZeneca Non-alcoholic Steatohepatitis Product Overview
10.1.3 AstraZeneca Non-alcoholic Steatohepatitis Product Market Performance
10.1.4 AstraZeneca Business Overview
10.1.5 AstraZeneca Non-alcoholic Steatohepatitis SWOT Analysis
10.1.6 AstraZeneca Recent Developments
10.2 Pfizer
10.2.1 Pfizer Non-alcoholic Steatohepatitis Basic Information
10.2.2 Pfizer Non-alcoholic Steatohepatitis Product Overview
10.2.3 Pfizer Non-alcoholic Steatohepatitis Product Market Performance
10.2.4 Pfizer Business Overview
10.2.5 Pfizer Non-alcoholic Steatohepatitis SWOT Analysis
10.2.6 Pfizer Recent Developments
10.3 GSK
10.3.1 GSK Non-alcoholic Steatohepatitis Basic Information
10.3.2 GSK Non-alcoholic Steatohepatitis Product Overview
10.3.3 GSK Non-alcoholic Steatohepatitis Product Market Performance
10.3.4 GSK Non-alcoholic Steatohepatitis SWOT Analysis
10.3.5 GSK Business Overview
10.3.6 GSK Recent Developments
10.4 Novo Nordisk
10.4.1 Novo Nordisk Non-alcoholic Steatohepatitis Basic Information
10.4.2 Novo Nordisk Non-alcoholic Steatohepatitis Product Overview
10.4.3 Novo Nordisk Non-alcoholic Steatohepatitis Product Market Performance
10.4.4 Novo Nordisk Business Overview
10.4.5 Novo Nordisk Recent Developments
10.5 Roche
10.5.1 Roche Non-alcoholic Steatohepatitis Basic Information
10.5.2 Roche Non-alcoholic Steatohepatitis Product Overview
10.5.3 Roche Non-alcoholic Steatohepatitis Product Market Performance
10.5.4 Roche Business Overview
10.5.5 Roche Recent Developments
10.6 AbbVie
10.6.1 AbbVie Non-alcoholic Steatohepatitis Basic Information
10.6.2 AbbVie Non-alcoholic Steatohepatitis Product Overview
10.6.3 AbbVie Non-alcoholic Steatohepatitis Product Market Performance
10.6.4 AbbVie Business Overview
10.6.5 AbbVie Recent Developments
10.7 Galectin Therapeutics
10.7.1 Galectin Therapeutics Non-alcoholic Steatohepatitis Basic Information
10.7.2 Galectin Therapeutics Non-alcoholic Steatohepatitis Product Overview
10.7.3 Galectin Therapeutics Non-alcoholic Steatohepatitis Product Market Performance
10.7.4 Galectin Therapeutics Business Overview
10.7.5 Galectin Therapeutics Recent Developments
10.8 Galmed Pharmaceuticals
10.8.1 Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Basic Information
10.8.2 Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Product Overview
10.8.3 Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Product Market Performance
10.8.4 Galmed Pharmaceuticals Business Overview
10.8.5 Galmed Pharmaceuticals Recent Developments
10.9 Gilead
10.9.1 Gilead Non-alcoholic Steatohepatitis Basic Information
10.9.2 Gilead Non-alcoholic Steatohepatitis Product Overview
10.9.3 Gilead Non-alcoholic Steatohepatitis Product Market Performance
10.9.4 Gilead Business Overview
10.9.5 Gilead Recent Developments
10.10 Intercept pharma
10.10.1 Intercept pharma Non-alcoholic Steatohepatitis Basic Information
10.10.2 Intercept pharma Non-alcoholic Steatohepatitis Product Overview
10.10.3 Intercept pharma Non-alcoholic Steatohepatitis Product Market Performance
10.10.4 Intercept pharma Business Overview
10.10.5 Intercept pharma Recent Developments
10.11 Non-alcoholic Steatohepatitis
10.11.1 Non-alcoholic Steatohepatitis Non-alcoholic Steatohepatitis Basic Information
10.11.2 Non-alcoholic Steatohepatitis Non-alcoholic Steatohepatitis Product Overview
10.11.3 Non-alcoholic Steatohepatitis Non-alcoholic Steatohepatitis Product Market Performance
10.11.4 Non-alcoholic Steatohepatitis Business Overview
10.11.5 Non-alcoholic Steatohepatitis Recent Developments
10.12 Takeda
10.12.1 Takeda Non-alcoholic Steatohepatitis Basic Information
10.12.2 Takeda Non-alcoholic Steatohepatitis Product Overview
10.12.3 Takeda Non-alcoholic Steatohepatitis Product Market Performance
10.12.4 Takeda Business Overview
10.12.5 Takeda Recent Developments
11 Non-alcoholic Steatohepatitis Market Forecast by Region
11.1 Global Non-alcoholic Steatohepatitis Market Size Forecast
11.2 Global Non-alcoholic Steatohepatitis Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Non-alcoholic Steatohepatitis Market Size Forecast by Country
11.2.3 Asia Pacific Non-alcoholic Steatohepatitis Market Size Forecast by Region
11.2.4 South America Non-alcoholic Steatohepatitis Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Non-alcoholic Steatohepatitis by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Non-alcoholic Steatohepatitis Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Non-alcoholic Steatohepatitis by Type (2025-2032)
12.1.2 Global Non-alcoholic Steatohepatitis Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Non-alcoholic Steatohepatitis by Type (2025-2032)
12.2 Global Non-alcoholic Steatohepatitis Market Forecast by Application (2025-2032)
12.2.1 Global Non-alcoholic Steatohepatitis Sales (K Units) Forecast by Application
12.2.2 Global Non-alcoholic Steatohepatitis Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Non-alcoholic Steatohepatitis Market Size Comparison by Region (M USD)
Table 5. Global Non-alcoholic Steatohepatitis Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Non-alcoholic Steatohepatitis Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Non-alcoholic Steatohepatitis Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Non-alcoholic Steatohepatitis Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-alcoholic Steatohepatitis as of 2022)
Table 10. Global Market Non-alcoholic Steatohepatitis Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Non-alcoholic Steatohepatitis Sales Sites and Area Served
Table 12. Manufacturers Non-alcoholic Steatohepatitis Product Type
Table 13. Global Non-alcoholic Steatohepatitis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Non-alcoholic Steatohepatitis
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Non-alcoholic Steatohepatitis Market Challenges
Table 22. Global Non-alcoholic Steatohepatitis Sales by Type (K Units)
Table 23. Global Non-alcoholic Steatohepatitis Market Size by Type (M USD)
Table 24. Global Non-alcoholic Steatohepatitis Sales (K Units) by Type (2019-2025)
Table 25. Global Non-alcoholic Steatohepatitis Sales Market Share by Type (2019-2025)
Table 26. Global Non-alcoholic Steatohepatitis Market Size (M USD) by Type (2019-2025)
Table 27. Global Non-alcoholic Steatohepatitis Market Size Share by Type (2019-2025)
Table 28. Global Non-alcoholic Steatohepatitis Price (USD/Unit) by Type (2019-2025)
Table 29. Global Non-alcoholic Steatohepatitis Sales (K Units) by Application
Table 30. Global Non-alcoholic Steatohepatitis Market Size by Application
Table 31. Global Non-alcoholic Steatohepatitis Sales by Application (2019-2025) & (K Units)
Table 32. Global Non-alcoholic Steatohepatitis Sales Market Share by Application (2019-2025)
Table 33. Global Non-alcoholic Steatohepatitis Sales by Application (2019-2025) & (M USD)
Table 34. Global Non-alcoholic Steatohepatitis Market Share by Application (2019-2025)
Table 35. Global Non-alcoholic Steatohepatitis Sales Growth Rate by Application (2019-2025)
Table 36. Global Non-alcoholic Steatohepatitis Sales by Region (2019-2025) & (K Units)
Table 37. Global Non-alcoholic Steatohepatitis Sales Market Share by Region (2019-2025)
Table 38. North America Non-alcoholic Steatohepatitis Sales by Country (2019-2025) & (K Units)
Table 39. Europe Non-alcoholic Steatohepatitis Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Non-alcoholic Steatohepatitis Sales by Region (2019-2025) & (K Units)
Table 41. South America Non-alcoholic Steatohepatitis Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Non-alcoholic Steatohepatitis Sales by Region (2019-2025) & (K Units)
Table 43. Global Non-alcoholic Steatohepatitis Production (K Units) by Region (2019-2025)
Table 44. Global Non-alcoholic Steatohepatitis Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Non-alcoholic Steatohepatitis Revenue Market Share by Region (2019-2025)
Table 46. Global Non-alcoholic Steatohepatitis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Non-alcoholic Steatohepatitis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Non-alcoholic Steatohepatitis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Non-alcoholic Steatohepatitis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Non-alcoholic Steatohepatitis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. AstraZeneca Non-alcoholic Steatohepatitis Basic Information
Table 52. AstraZeneca Non-alcoholic Steatohepatitis Product Overview
Table 53. AstraZeneca Non-alcoholic Steatohepatitis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. AstraZeneca Business Overview
Table 55. AstraZeneca Non-alcoholic Steatohepatitis SWOT Analysis
Table 56. AstraZeneca Recent Developments
Table 57. Pfizer Non-alcoholic Steatohepatitis Basic Information
Table 58. Pfizer Non-alcoholic Steatohepatitis Product Overview
Table 59. Pfizer Non-alcoholic Steatohepatitis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Pfizer Business Overview
Table 61. Pfizer Non-alcoholic Steatohepatitis SWOT Analysis
Table 62. Pfizer Recent Developments
Table 63. GSK Non-alcoholic Steatohepatitis Basic Information
Table 64. GSK Non-alcoholic Steatohepatitis Product Overview
Table 65. GSK Non-alcoholic Steatohepatitis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. GSK Non-alcoholic Steatohepatitis SWOT Analysis
Table 67. GSK Business Overview
Table 68. GSK Recent Developments
Table 69. Novo Nordisk Non-alcoholic Steatohepatitis Basic Information
Table 70. Novo Nordisk Non-alcoholic Steatohepatitis Product Overview
Table 71. Novo Nordisk Non-alcoholic Steatohepatitis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Novo Nordisk Business Overview
Table 73. Novo Nordisk Recent Developments
Table 74. Roche Non-alcoholic Steatohepatitis Basic Information
Table 75. Roche Non-alcoholic Steatohepatitis Product Overview
Table 76. Roche Non-alcoholic Steatohepatitis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. Roche Business Overview
Table 78. Roche Recent Developments
Table 79. AbbVie Non-alcoholic Steatohepatitis Basic Information
Table 80. AbbVie Non-alcoholic Steatohepatitis Product Overview
Table 81. AbbVie Non-alcoholic Steatohepatitis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. AbbVie Business Overview
Table 83. AbbVie Recent Developments
Table 84. Galectin Therapeutics Non-alcoholic Steatohepatitis Basic Information
Table 85. Galectin Therapeutics Non-alcoholic Steatohepatitis Product Overview
Table 86. Galectin Therapeutics Non-alcoholic Steatohepatitis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Galectin Therapeutics Business Overview
Table 88. Galectin Therapeutics Recent Developments
Table 89. Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Basic Information
Table 90. Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Product Overview
Table 91. Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Galmed Pharmaceuticals Business Overview
Table 93. Galmed Pharmaceuticals Recent Developments
Table 94. Gilead Non-alcoholic Steatohepatitis Basic Information
Table 95. Gilead Non-alcoholic Steatohepatitis Product Overview
Table 96. Gilead Non-alcoholic Steatohepatitis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Gilead Business Overview
Table 98. Gilead Recent Developments
Table 99. Intercept pharma Non-alcoholic Steatohepatitis Basic Information
Table 100. Intercept pharma Non-alcoholic Steatohepatitis Product Overview
Table 101. Intercept pharma Non-alcoholic Steatohepatitis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. Intercept pharma Business Overview
Table 103. Intercept pharma Recent Developments
Table 104. Non-alcoholic Steatohepatitis Non-alcoholic Steatohepatitis Basic Information
Table 105. Non-alcoholic Steatohepatitis Non-alcoholic Steatohepatitis Product Overview
Table 106. Non-alcoholic Steatohepatitis Non-alcoholic Steatohepatitis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 107. Non-alcoholic Steatohepatitis Business Overview
Table 108. Non-alcoholic Steatohepatitis Recent Developments
Table 109. Takeda Non-alcoholic Steatohepatitis Basic Information
Table 110. Takeda Non-alcoholic Steatohepatitis Product Overview
Table 111. Takeda Non-alcoholic Steatohepatitis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 112. Takeda Business Overview
Table 113. Takeda Recent Developments
Table 114. Global Non-alcoholic Steatohepatitis Sales Forecast by Region (2025-2032) & (K Units)
Table 115. Global Non-alcoholic Steatohepatitis Market Size Forecast by Region (2025-2032) & (M USD)
Table 116. North America Non-alcoholic Steatohepatitis Sales Forecast by Country (2025-2032) & (K Units)
Table 117. North America Non-alcoholic Steatohepatitis Market Size Forecast by Country (2025-2032) & (M USD)
Table 118. Europe Non-alcoholic Steatohepatitis Sales Forecast by Country (2025-2032) & (K Units)
Table 119. Europe Non-alcoholic Steatohepatitis Market Size Forecast by Country (2025-2032) & (M USD)
Table 120. Asia Pacific Non-alcoholic Steatohepatitis Sales Forecast by Region (2025-2032) & (K Units)
Table 121. Asia Pacific Non-alcoholic Steatohepatitis Market Size Forecast by Region (2025-2032) & (M USD)
Table 122. South America Non-alcoholic Steatohepatitis Sales Forecast by Country (2025-2032) & (K Units)
Table 123. South America Non-alcoholic Steatohepatitis Market Size Forecast by Country (2025-2032) & (M USD)
Table 124. Middle East and Africa Non-alcoholic Steatohepatitis Consumption Forecast by Country (2025-2032) & (Units)
Table 125. Middle East and Africa Non-alcoholic Steatohepatitis Market Size Forecast by Country (2025-2032) & (M USD)
Table 126. Global Non-alcoholic Steatohepatitis Sales Forecast by Type (2025-2032) & (K Units)
Table 127. Global Non-alcoholic Steatohepatitis Market Size Forecast by Type (2025-2032) & (M USD)
Table 128. Global Non-alcoholic Steatohepatitis Price Forecast by Type (2025-2032) & (USD/Unit)
Table 129. Global Non-alcoholic Steatohepatitis Sales (K Units) Forecast by Application (2025-2032)
Table 130. Global Non-alcoholic Steatohepatitis Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Non-alcoholic Steatohepatitis
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Non-alcoholic Steatohepatitis Market Size (M USD), 2019-2032
Figure 5. Global Non-alcoholic Steatohepatitis Market Size (M USD) (2019-2032)
Figure 6. Global Non-alcoholic Steatohepatitis Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Non-alcoholic Steatohepatitis Market Size by Country (M USD)
Figure 11. Non-alcoholic Steatohepatitis Sales Share by Manufacturers in 2023
Figure 12. Global Non-alcoholic Steatohepatitis Revenue Share by Manufacturers in 2023
Figure 13. Non-alcoholic Steatohepatitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Non-alcoholic Steatohepatitis Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Non-alcoholic Steatohepatitis Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Non-alcoholic Steatohepatitis Market Share by Type
Figure 18. Sales Market Share of Non-alcoholic Steatohepatitis by Type (2019-2025)
Figure 19. Sales Market Share of Non-alcoholic Steatohepatitis by Type in 2023
Figure 20. Market Size Share of Non-alcoholic Steatohepatitis by Type (2019-2025)
Figure 21. Market Size Market Share of Non-alcoholic Steatohepatitis by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Non-alcoholic Steatohepatitis Market Share by Application
Figure 24. Global Non-alcoholic Steatohepatitis Sales Market Share by Application (2019-2025)
Figure 25. Global Non-alcoholic Steatohepatitis Sales Market Share by Application in 2023
Figure 26. Global Non-alcoholic Steatohepatitis Market Share by Application (2019-2025)
Figure 27. Global Non-alcoholic Steatohepatitis Market Share by Application in 2023
Figure 28. Global Non-alcoholic Steatohepatitis Sales Growth Rate by Application (2019-2025)
Figure 29. Global Non-alcoholic Steatohepatitis Sales Market Share by Region (2019-2025)
Figure 30. North America Non-alcoholic Steatohepatitis Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Non-alcoholic Steatohepatitis Sales Market Share by Country in 2023
Figure 32. U.S. Non-alcoholic Steatohepatitis Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Non-alcoholic Steatohepatitis Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Non-alcoholic Steatohepatitis Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Non-alcoholic Steatohepatitis Sales Market Share by Country in 2023
Figure 37. Germany Non-alcoholic Steatohepatitis Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Non-alcoholic Steatohepatitis Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Non-alcoholic Steatohepatitis Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Non-alcoholic Steatohepatitis Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Non-alcoholic Steatohepatitis Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Non-alcoholic Steatohepatitis Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Non-alcoholic Steatohepatitis Sales Market Share by Region in 2023
Figure 44. China Non-alcoholic Steatohepatitis Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Non-alcoholic Steatohepatitis Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Non-alcoholic Steatohepatitis Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Non-alcoholic Steatohepatitis Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Non-alcoholic Steatohepatitis Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Non-alcoholic Steatohepatitis Sales and Growth Rate (K Units)
Figure 50. South America Non-alcoholic Steatohepatitis Sales Market Share by Country in 2023
Figure 51. Brazil Non-alcoholic Steatohepatitis Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Non-alcoholic Steatohepatitis Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Non-alcoholic Steatohepatitis Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Non-alcoholic Steatohepatitis Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Non-alcoholic Steatohepatitis Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Non-alcoholic Steatohepatitis Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Non-alcoholic Steatohepatitis Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Non-alcoholic Steatohepatitis Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Non-alcoholic Steatohepatitis Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Non-alcoholic Steatohepatitis Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Non-alcoholic Steatohepatitis Production Market Share by Region (2019-2025)
Figure 62. North America Non-alcoholic Steatohepatitis Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Non-alcoholic Steatohepatitis Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Non-alcoholic Steatohepatitis Production (K Units) Growth Rate (2019-2025)
Figure 65. China Non-alcoholic Steatohepatitis Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Non-alcoholic Steatohepatitis Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Non-alcoholic Steatohepatitis Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Non-alcoholic Steatohepatitis Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Non-alcoholic Steatohepatitis Market Share Forecast by Type (2025-2032)
Figure 70. Global Non-alcoholic Steatohepatitis Sales Forecast by Application (2025-2032)
Figure 71. Global Non-alcoholic Steatohepatitis Market Share Forecast by Application (2025-2032)
